Castle Biosciences Inc
CSTL15.051USD
+0.401+2.74%
交易中 （美东）报价延迟15分钟
434.15M总市值
亏损市盈率 TTM
关于 Castle Biosciences Inc 公司
Castle Biosciences, Inc. 是一家商业阶段诊断公司。该公司专注于为医生及其患者提供个性化、临床可操作的信息，以便医生及其患者做出治疗决策并改善健康结果。其产品组合包括皮肤癌、葡萄膜黑色素瘤、巴雷特食管和精神健康状况的检测。其产品包括 DecisionDx-Melanoma、DecisionDx-SCC、MyPath Melanoma、TissueCypher 和 DecisionDx-UM、IDgenetix。DecisionDx-Melanoma 是一种风险分层基因表达谱 (GEP) 测试，可预测被诊断为侵袭性皮肤黑色素瘤 (CM)（一种致命皮肤癌）的患者的转移或复发风险。MyPath Melanoma 是针对难以诊断的黑色素细胞病变患者的 GEP 测试。 IDgenetix 是一种药物基因组学 (PGx) 测试，有助于指导患有重度抑郁症、躁郁症等的患者进行最佳药物治疗。
公司简介
公司代码CSTL
公司名称Castle Biosciences Inc
上市日期Jul 25, 2019
CEOMr. Derek J. Maetzold
员工数量761
证券类型Ordinary Share
年结日Jul 25
公司地址505 S Friendswood Drive
城市FRIENDSWOOD
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编77546
电话18667889007
网址https://castlebiosciences.com/
公司代码CSTL
上市日期Jul 25, 2019
CEOMr. Derek J. Maetzold
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Derek J. Maetzold
Mr. Derek J. Maetzold
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
361.91K
-1.35%
Ms. Kristen M. Oelschlager
Ms. Kristen M. Oelschlager
Chief Operating Officer
Chief Operating Officer
163.96K
+7.62%
Mr. Tobin W. (Toby) Juvenal
Mr. Tobin W. (Toby) Juvenal
Chief Commercial Officer
Chief Commercial Officer
80.41K
+11.41%
Mr. Frank Stokes
Mr. Frank Stokes
Chief Financial Officer
Chief Financial Officer
43.33K
+22.68%
Ms. Ellen Goldberg
Ms. Ellen Goldberg
Independent Director
Independent Director
27.25K
+46.68%
Mr. Miles D. Harrison
Mr. Miles D. Harrison
Independent Director
Independent Director
21.96K
+65.25%
Mr. Rodney Cotton
Mr. Rodney Cotton
Independent Director
Independent Director
19.33K
+81.38%
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Independent Director
Independent Director
--
--
Ms. Kimberlee S. Caple
Ms. Kimberlee S. Caple
Independent Director
Independent Director
--
--
Mr. Daniel Mark (Dan) Bradbury
Mr. Daniel Mark (Dan) Bradbury
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Derek J. Maetzold
Mr. Derek J. Maetzold
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
361.91K
-1.35%
Ms. Kristen M. Oelschlager
Ms. Kristen M. Oelschlager
Chief Operating Officer
Chief Operating Officer
163.96K
+7.62%
Mr. Tobin W. (Toby) Juvenal
Mr. Tobin W. (Toby) Juvenal
Chief Commercial Officer
Chief Commercial Officer
80.41K
+11.41%
Mr. Frank Stokes
Mr. Frank Stokes
Chief Financial Officer
Chief Financial Officer
43.33K
+22.68%
Ms. Ellen Goldberg
Ms. Ellen Goldberg
Independent Director
Independent Director
27.25K
+46.68%
Mr. Miles D. Harrison
Mr. Miles D. Harrison
Independent Director
Independent Director
21.96K
+65.25%
收入明细
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
87.99M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 7月27日 周日
更新时间: 7月27日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.07%
Portolan Capital Management, L.L.C.
5.58%
Principal Global Investors (Equity)
5.08%
Dimensional Fund Advisors, L.P.
4.16%
Other
70.09%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
8.01%
The Vanguard Group, Inc.
7.07%
Portolan Capital Management, L.L.C.
5.58%
Principal Global Investors (Equity)
5.08%
Dimensional Fund Advisors, L.P.
4.16%
Other
70.09%
股东类型
持股股东
占比
Investment Advisor
37.18%
Investment Advisor/Hedge Fund
35.28%
Hedge Fund
15.91%
Individual Investor
2.91%
Research Firm
2.85%
Pension Fund
0.97%
Bank and Trust
0.48%
Venture Capital
0.07%
Corporation
0.05%
Other
4.30%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
403
27.71M
95.98%
-3.07M
2025Q1
423
27.42M
95.08%
-3.59M
2024Q4
413
27.81M
97.60%
-2.39M
2024Q3
414
27.79M
100.23%
-3.05M
2024Q2
400
27.44M
99.43%
-4.42M
2024Q1
407
28.20M
102.27%
-5.76M
2023Q4
407
26.80M
99.62%
-6.63M
2023Q3
416
26.10M
97.38%
-6.68M
2023Q2
414
24.88M
93.24%
-6.39M
2023Q1
420
24.03M
90.08%
-9.68M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
2.31M
8.01%
+53.08K
+2.35%
Mar 31, 2025
The Vanguard Group, Inc.
2.04M
7.07%
+215.03K
+11.77%
Mar 31, 2025
Portolan Capital Management, L.L.C.
1.61M
5.58%
+345.88K
+27.34%
Apr 07, 2025
Principal Global Investors (Equity)
1.47M
5.08%
+32.21K
+2.24%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.20M
4.16%
+200.76K
+20.09%
Mar 31, 2025
Wasatch Global Investors Inc
998.46K
3.46%
-797.63K
-44.41%
Mar 31, 2025
Wellington Management Company, LLP
828.53K
2.87%
+106.41K
+14.74%
Mar 31, 2025
Nuveen LLC
723.60K
2.51%
+369.89K
+104.57%
Mar 31, 2025
State Street Global Advisors (US)
715.03K
2.48%
+4.82K
+0.68%
Mar 31, 2025
Renaissance Technologies LLC
701.20K
2.43%
+16.20K
+2.36%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPDR S&P Health Care Services ETF
1.13%
Harbor Human Capital Factor US Small Cap ETF
0.27%
Royce Quant Small-Cap Quality Value ETF
0.25%
Inspire Small/Mid Cap ESG ETF
0.2%
iShares Micro-Cap ETF
0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
iShares U.S. Healthcare Providers ETF
0.09%
Avantis US Small Cap Equity ETF
0.07%
Invesco Nasdaq Biotechnology ETF
0.07%
Goldman Sachs Innovate Equity ETF
0.07%
查看更多
SPDR S&P Health Care Services ETF
占比1.13%
Harbor Human Capital Factor US Small Cap ETF
占比0.27%
Royce Quant Small-Cap Quality Value ETF
占比0.25%
Inspire Small/Mid Cap ESG ETF
占比0.2%
iShares Micro-Cap ETF
占比0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.11%
iShares U.S. Healthcare Providers ETF
占比0.09%
Avantis US Small Cap Equity ETF
占比0.07%
Invesco Nasdaq Biotechnology ETF
占比0.07%
Goldman Sachs Innovate Equity ETF
占比0.07%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
